We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Event
05 Jun 2020
Health

Financial Acumen for Executives in Pharma-Biotech-Medtech Licensing

1-Day Training Course with Michelle I Olufeso

Understand key financial and accounting terminology for licensing deals – Anticipate the financial/accounting implications of your decisions when assessing and negotiating licensing deals - Avoid the pitfalls caused by a lack of financial acumen in pharmaceutical licensing.

By attending this course you will learn;

  1. The types of financial statements and their components relevant for deal accounting.
  2. To understand the accounting terminology and implications of licensing contracts.
  3. How the classification of the IP transferred in a deal impacts on deal accounting.
  4. How to mitigate the risk of having income fluctuations in financial statements as a result of uncertainty around R&D deals.
  5. How to determine the accounting implications of in-licensing deals before deal signing.
  6. How to determine the accounting implications of out-licensing deals before deal signing.
  7. The accounting implications of equity transfers before deal signing.

 

 

When

5 Jun 2020 @ 10:00 am

5 Jun 2020 @ 05:30 pm

Duration: 7 hours, 30 minutes


Where

The Courtyard Marriott Hotel Brussels

6 Olympiadenlaan

1140 Evere

Belgium


Language

English en


Organised by

C.E.L.forpharma (deactivated)